178 related articles for article (PubMed ID: 2575471)
1. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
Mitchell JA; Sim RB; Sim E
Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
[TBL] [Abstract][Full Text] [Related]
4. Size polymorphism of the erythrocyte complement receptor type 1 (CR1) in systemic lupus erythematosus induced by hydralazine.
Mitchell JA; Sim E
Complement Inflamm; 1989; 6(2):88-93. PubMed ID: 2721176
[TBL] [Abstract][Full Text] [Related]
5. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
[TBL] [Abstract][Full Text] [Related]
6. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
[TBL] [Abstract][Full Text] [Related]
7. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1.
Satoh H; Yokota E; Tokiyama K; Kawaguchi T; Niho Y
Ann Rheum Dis; 1991 Nov; 50(11):765-8. PubMed ID: 1685310
[TBL] [Abstract][Full Text] [Related]
8. The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus.
Tebib JG; Martinez C; Granados J; Alarcon-Segovia D; Schur PH
Arthritis Rheum; 1989 Nov; 32(11):1465-9. PubMed ID: 2573360
[TBL] [Abstract][Full Text] [Related]
9. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus.
Cohen JH; Caudwell V; Levi-Strauss M; Bourgeois P; Kazatchkine MD
Arthritis Rheum; 1989 Apr; 32(4):393-7. PubMed ID: 2565113
[TBL] [Abstract][Full Text] [Related]
11. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
Moldenhauer F; Botto M; Walport MJ
Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
13. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
14. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
15. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
[TBL] [Abstract][Full Text] [Related]
16. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
17. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
18. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
19. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
20. Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups.
Moulds JM; Reveille JD; Arnett FC
Clin Exp Immunol; 1996 Aug; 105(2):302-5. PubMed ID: 8706338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
